“I would eat it with my eyes, but my stomach wouldn’t allow me!” — Panzest will help

Abstract

A new-generation enzyme preparation called Panzest is derived from non-animal enzymes. Given that Panzest is a pathogenetically established medication for overeating symptoms, it has the potential to become a “people’s” medicine that is an essential in every family’s first-aid kit. After a large meal, even healthy individuals experience heaviness and discomfort in the epigastrium, belching, heartburn, and bloating.

Duodenostasis is one of the first pathophysiological responses to overeating. The duodenum’s inadequately hydrolyzed chyme makes use of many reflex mechanisms to demand more pancreatic enzymes. Chyme remains in the duodenal lumen, waiting for more pancreatic enzymes, if the pancreas is unable to meet these demands. The pancreas only synthesizes and excretes them once again after a while. After the constituents of chyme have undergone enough hydrolysis, they will proceed with their transit through the digestive system. As a result, duodenostasis is caused by the retention of chyme in the duodenum after overeating. Pyloric spasm and delayed stomach emptying are always associated with it. After a large, fatty meal, duodeno- and gastrostasis is the reason for upper abdominal heaviness, bloating, and discomfort. Consequently, gastroesophageal reflux disease (which presents as heartburn and belching) is triggered by gastrostasis.

To address these issues, enzyme preparations are required. Panzest is the best option in this situation. The key ingredients of Panzest are non-animal lipolytic, amylolytic, and proteolytic enzymes, which provide many notable advantages over animal-derived enzymes (like pancreatin). The initial novel enzyme delivery system, known as a “capsule in a capsule”, is of utmost significance. It consists of internal and external capsules into which the drug’s components are separated, enabling the delivery of active ingredients to specific gastrointestinal tract sections based on the pH environment. Excessive consumption of fruits and vegetables may also exacerbate the symptoms of overeating, including flatulence. Panzest’s constituent enzymes, alpha-galactosidase and glucoseamylase, help cope with this symptom. The components of Panzest thoroughly address the potential pathways underlying the etiology of symptoms associated with overeating.